GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (OSTO:ALIF B) » Definitions » EV-to-Revenue

AddLife AB (OSTO:ALIF B) EV-to-Revenue : 1.94 (As of May. 24, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AddLife AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, AddLife AB's enterprise value is kr19,052 Mil. AddLife AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr9,798 Mil. Therefore, AddLife AB's EV-to-Revenue for today is 1.94.

The historical rank and industry rank for AddLife AB's EV-to-Revenue or its related term are showing as below:

OSTO:ALIF B' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.33   Med: 2.3   Max: 7.33
Current: 1.94

During the past 11 years, the highest EV-to-Revenue of AddLife AB was 7.33. The lowest was 1.33. And the median was 2.30.

OSTO:ALIF B's EV-to-Revenue is ranked better than
65.54% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: 3.23 vs OSTO:ALIF B: 1.94

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-24), AddLife AB's stock price is kr113.20. AddLife AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr80.40. Therefore, AddLife AB's PS Ratio for today is 1.41.


AddLife AB EV-to-Revenue Historical Data

The historical data trend for AddLife AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB EV-to-Revenue Chart

AddLife AB Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.56 3.19 6.29 2.03 1.89

AddLife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 2.21 1.41 1.89 1.93

Competitive Comparison of AddLife AB's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, AddLife AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where AddLife AB's EV-to-Revenue falls into.



AddLife AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

AddLife AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=19052.012/9798
=1.94

AddLife AB's current Enterprise Value is kr19,052 Mil.
AddLife AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9,798 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AddLife AB  (OSTO:ALIF B) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

AddLife AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=113.20/80.403
=1.41

AddLife AB's share price for today is kr113.20.
AddLife AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr80.40.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AddLife AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of AddLife AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB (OSTO:ALIF B) Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB (OSTO:ALIF B) Headlines

No Headlines